Details for Patent: 10,882,840
✉ Email this page to a colleague
Which drugs does patent 10,882,840 protect, and when does it expire?
Patent 10,882,840 protects RHOPRESSA and ROCKLATAN and is included in two NDAs.
This patent has nine patent family members in six countries.
Drugs Protected by US Patent 10,882,840
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | 10,882,840 | ⤷ Subscribe | REDUCTION OF ELEVATED INTRAOCULAR PRESSURE | ⤷ Subscribe | ||||
| Alcon Labs Inc | ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259-001 | Mar 12, 2019 | RX | Yes | Yes | 10,882,840 | ⤷ Subscribe | REDUCTION OF ELEVATED INTRAOCULAR PRESSURE | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,882,840
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009273932 | ⤷ Subscribe | |||
| Canada | 2731869 | ⤷ Subscribe | |||
| European Patent Office | 2326623 | ⤷ Subscribe | |||
| Spain | 2474150 | ⤷ Subscribe | |||
| Japan | 2011529074 | ⤷ Subscribe | |||
| Japan | 2014208681 | ⤷ Subscribe | |||
| Japan | 5643758 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
